(NASDAQ: AVR) Anteris Technologies Global's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 19.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.21%.
Anteris Technologies Global's earnings in 2025 is -$83,931,832.On average, 3 Wall Street analysts forecast AVR's earnings for 2025 to be -$85,594,035, with the lowest AVR earnings forecast at -$85,525,517, and the highest AVR earnings forecast at -$86,333,314. On average, 3 Wall Street analysts forecast AVR's earnings for 2026 to be -$72,665,676, with the lowest AVR earnings forecast at -$84,818,694, and the highest AVR earnings forecast at -$60,206,127.
In 2027, AVR is forecast to generate -$64,284,781 in earnings, with the lowest earnings forecast at -$79,870,937 and the highest earnings forecast at -$48,089,170.